PARNATE (Concordia Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the PARNATE drug offered from Concordia Pharmaceuticals Inc.. This Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Concordia Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | tranylcypromine sulfate |
SUBSTANCE NAME: | TRANYLCYPROMINE SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-01-14 |
END MARKETING DATE: | 0000-00-00 |
PARNATE HUMAN PRESCRIPTION DRUG Details:
Item Description | PARNATE from Concordia Pharmaceuticals Inc. |
LABELER NAME: | Concordia Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2013-01-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 59212-447_368a612e-0c3c-4502-826a-7925e03f43d0 |
PRODUCT NDC: | 59212-447 |
APPLICATION NUMBER: | NDA012342 |
Other TRANYLCYPROMINE SULFATE Pharmaceutical Manufacturers / Labelers: